Not exact matches
A scientist from the NIH was one author
of the paper describing the discovery, but Myriad Pharmaceuticals, which
signed an exclusive licence
with the University
of Utah where the rest
of the research was done, doesn't seem interested in sharing the profits if a
breast cancer screening test is devised based on the discovery.
As a 38 - year - old woman, on the other hand, I've had little personal experience
with this imaging tool, which takes X-ray photos
of each
breast to screen for possible
signs of breast cancer.
Some women who have been diagnosed
with cancer in one
breast, particularly those who are known to be at very high risk, may consider having the other
breast (called the contralateral
breast) removed as well, even if there is no
sign of cancer in that
breast.
The following ailments found in two family members may be a
sign of hereditary
cancer: •
Breast cancer (one before age 50) • Ovarian cancer at any age • One with breast cancer and one with ovarian
Breast cancer (one before age 50) • Ovarian
cancer at any age • One
with breast cancer and one with ovarian
breast cancer and one
with ovarian
cancer
If the test indicates possible early warning
signs of cancer, a physician's failure to follow - up
with the patient by ordering further tests such as a
breast X-ray, ultrasound, MRI or biopsy could also lead to unnecessary delays in diagnosing
breast cancer.